Home
/ Patrys
/ Competitors

Patrys Competitors and Similar CompaniesClear all

Patrys's competitors and similar companies include Stemline Therapeutics, Exelixis and TRACON Pharmaceuticals.

	Patrys Patrys is a drug development company that commercializes antibody technologies for the treatment of cancer.	Stemline Therapeutics Stemline Therapeutics is a clinical stage biopharmaceutical company developing oncology compounds that target cancer stem cells.	Exelixis Exelixis is an oncology company that develops cancer treatments.	TRACON Pharmaceuticals TRACON Pharmaceuticals is a biopharmaceutical company focused on developing targeted therapies for cancer and macular degeneration.
Founding Date	Founding Date 2007	Founding Date 2003	Founding Date 1994	Founding Date 2006
Type	Type Public	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations South Melbourne, AU HQ	Locations New York, US HQ	Locations Alameda, US HQ	Locations San Diego, US HQ
Employees	Employees N/A	Employees 100	Employees 1,14712% decrease	Employees 268% increase
Valuation ($)	Valuation ($) 5.4 m	Valuation ($) 621.2 m	Valuation ($) 8.2 b	Valuation ($) 279.4 k
Financial
Revenue (est.)	Revenue (est.) $807k (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $2.3b (FY, 2025)	Revenue (est.) $12m (FY, 2023)
Cost of goods	Cost of goods N/A	Cost of goods $4.9m (FY, 2019)	Cost of goods $83.7m (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit $807k (FY, 2025)	Gross profit N/A	Gross profit $2.2b (FY, 2025)	Gross profit N/A
Net income	Net income ($3m) (FY, 2025)	Net income ($76.8m) (FY, 2019)	Net income $782.6m (FY, 2025)	Net income ($3.6m) (FY, 2023)